Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ulrik Bodholdt"'
Autor:
Thozhukat Sathyapalan, Andrei-Mircea Catarig, Patrick Holmes, Jean-François Yale, Ulrik Bodholdt, Sergiu Catrina, Alice Clark, Neda Rajamand Ekberg, Umut Erhan, Søren Tang Knudsen, Joanne Liutkus, Bernd Schultes, Gottfried Rudofsky
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 10, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/c62708ce246d49819106d68b235a3c72
Autor:
Neda Rajamand Ekberg, Boris Klanger, Katrine Grau, Ulrik Bodholdt, Sergiu-Bogdan Catrina, Cecilia Nagorny Holmberg, Andrei-Mircea Catarig, Søren Tang Knudsen
Publikováno v:
Rajamand Ekberg, N, Bodholdt, U, Catarig, A M, Catrina, S B, Grau, K, Holmberg, C N, Klanger, B & Knudsen, S T 2021, ' Real-world use of once-weekly semaglutide in patients with type 2 diabetes : Results from the SURE Denmark/Sweden multicentre, prospective, observational study ', Primary Care Diabetes, vol. 15, no. 5, pp. 871-878 . https://doi.org/10.1016/j.pcd.2021.06.008
Aims: As part of the SURE programme, SURE Denmark/Sweden aimed to study the real-world use of once-weekly (OW) semaglutide in adults with type 2 diabetes (T2D) in Denmark/Sweden. Methods: SURE Denmark/Sweden was an ∼30-week, prospective, multicentr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0472276e0401fb787fa5ce67a816d5d
https://pure.au.dk/ws/files/274251141/1_s2.0_S1751991821001121_main.pdf
https://pure.au.dk/ws/files/274251141/1_s2.0_S1751991821001121_main.pdf
Publikováno v:
Diabetes. 70
A mobile health application (mHealth app) with treatment planning, body weight and dose tracking features has been developed to support patients with type 2 diabetes (T2D) initiating once-weekly (OW) semaglutide, a glucagon-like peptide-1 analog. Her
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce867cff53932a7f126d260e86825349
https://doi.org/10.2337/db21-645-p
https://doi.org/10.2337/db21-645-p
Autor:
Jean-François Yale, Ulrik Bodholdt, Andrei-Mircea Catarig, Sergiu Catrina, Alice Clark, Neda Rajamand Ekberg, Umut Erhan, Patrick Holmes, Søren Tang Knudsen, Joanne Liutkus, Thozhukat Sathyapalan, Bernd Schultes, Gottfried Rudofsky
Publikováno v:
Yale, J F, Bodholdt, U, Catarig, A M, Catrina, S, Clark, A, Ekberg, N R, Erhan, U, Holmes, P, Knudsen, S T, Liutkus, J, Sathyapalan, T, Schultes, B & Rudofsky, G 2022, ' Real-world use of once-weekly semaglutide in patients with type 2 diabetes : Pooled analysis of data from four SURE studies by baseline characteristic subgroups ', BMJ Open Diabetes Research and Care, vol. 10, no. 2, e002619 . https://doi.org/10.1136/bmjdrc-2021-002619
IntroductionThis post hoc pooled analysis of four real-world studies (SURE Canada, Denmark/Sweden, Switzerland and UK) aimed to characterize the use of once-weekly (OW) semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4416e9a70fc551fba064bcfa935f6206
https://doi.org/10.1136/bmjdrc-2021-002619
https://doi.org/10.1136/bmjdrc-2021-002619